News
For now, CVS declines to cover Gilead's long-acting HIV PrEP treatment Yeztugo
The owner of the United States' largest pharmacy benefit manager (PBM) is declining to cover Gilead Sciences’ long-acting HIV prevention breakthrough, at least for now. | CVS Health, the parent of PBM juggernaut CVS Caremark,
LGBTQ Nation on MSN5h
Religious-fueled HIV stigma remains rampant. This iconic playwright uses his art to fight it.
Michael R. Jackson's hit Broadway musical, A Strange Loop, was in part inspired by the crass way HIV was treated by Tyler ...
Patients with acute HIV infection who initiate dolutegravir/abacavir/lamivudine therapy have greater increases in BMI, ...
A vaccine successfully induced specific B cells in rhesus macaques, paving the way for an effective HIV vaccine in humans.
This August, First Baptist Church in Austin hosts a memorial that renders that faith tangible.
For more than 20 years, Harvard infectious disease specialist Roger Shapiro has fought HIV on the ground in Botswana, where ...
The Trump administration is failing to fully fund the President's Emergency Plan for AIDS Relief (PEPFAR), contrary to ...
Honesty Bishop, a transgender woman, was held in solitary confinement for six years after being assaulted by her cellmate at ...
Living with HIV? Thanks to medical advances, you can still have a long, healthy life in front of you. Seeing your doctor ...
Antiretroviral treatments for HIV (human immunodeficiency virus) have been extremely successful in extending life expectancy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback